Proteotype Launches €3 Million European Study to Advance Multi-Cancer Detection and Evaluate Home Blood Collection
The INNOVATOR study will expand validation of Enlighten® across 12 cancers and assess whether capillary blood collection could enable a future laboratory-based test using samples collected at home. TORRES VEDRAS, Portugal, July 30, 2026 /PRNewswire/ -- Proteotype Diagnostics Unipessoal...
The INNOVATOR study will expand validation of Enlighten® across 12 cancers and assess whether capillary blood collection could enable a future laboratory-based test using samples collected at home. TORRES VEDRAS, Portugal, July 30, 2026 /PRNewswire/ -- Proteotype Diagnostics Unipessoal...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.